Author

J. Kreye

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Immunology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Research Focus:host-pathogen & immune response· 5 Assay:proteomics· 4 Organism:human· 2 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

E. Sanchez-Sendin· 4 shared M. Yuan· 4 shared S. M. Reincke· 4 shared C.-C. D. Lee· 3 shared H. Liu· 3 shared H.-C. Kornau· 3 shared I. A. Wilson· 3 shared N. C. Wu· 3 shared

Activity by Year

2020-2023 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

E. Sanchez-Sendin

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Gain efficiency with streamlined and automated data processing: Examples from high-throughput monoclonal antibody production

M. Kotowicz, S. Fengler, B. Kurkowsky, A. Meyer-Berhorn, E. Moretti, J. Blersch, M. Shumanska, G. Schmidt, J. Kreye, S. van Hoof, E. Sanchez-Sendin, M. Reincke, L. Krueger, H. Pruess, P. Denner, , D. Stappert

The paper presents a modular data processing pipeline to streamline and automate data management in complex biological workflows, enhancing reproducibility and compliance with FAIR principles.

bioRxiv · Dec 14, 2023Cell Biology

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

S. M. Reincke, M. Yuan, H.-C. Kornau, V. M. Corman, S. van Hoof, E. Sanchez-Sendin, M. Ramberger, W. Yu, Y. Hua, H. Tien, M. L. Schmidt, T. Schwarz, L. M. Jeworowski, S. E. Brandl, H. Foverskov Rasmussen, , J. Kreye

SARS-CoV-2 Beta variant infection generates lineage-specific antibodies and cross-reactive antibodies with neutralizing activity against wild-type and other variants.

bioRxiv · Sep 30, 2021Immunology

Induction of cross-reactive antibody responses against the RBD domain of the spike protein of SARS-CoV-2 by commensal microbiota

J. Ninnemann, L. Budzinski, M. Bondareva, M. Witkowski, S. Angermair, J. Kreye, P. Durek, M. Reincke, E. Sanchez-Sendin, S. Yilmaz, T. Sempert, G. A. Heinz, C. Tizian, M. Raftery, G. Schoenrich, , A. Kruglov

This study identifies commensal bacteria that induce cross-reactive anti-RBD IgA antibodies against SARS-CoV-2 in humans and mice.

bioRxiv · Aug 8, 2021 · PreprintMicrobiology

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants

M. Yuan, D. Huang, C.-C. D. Lee, N. C. Wu, A. M. Jackson, X. Zhu, H. Liu, L. Peng, M. J. van Gils, R. W. Sanders, D. R. Burton, S. M. Reincke, H. Prüss, J. Kreye, D. Nemazee, , I. A. Wilson

The paper examines how mutations at E484 and K417 in SARS-CoV-2 variants affect neutralizing antibodies, showing reduced efficacy against certain antibody families but not others.

bioRxiv · Feb 16, 2021Microbiology

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection

H. Liu, M. Yuan, D. Huang, S. Bangaru, C.-C. D. Lee, L. Peng, X. Zhu, D. Nemazee, M. J. van Gils, R. W. Sanders, H.-C. Kornau, S. M. Reincke, H. Pruss, J. Kreye, N. C. Wu, , I. A. Wilson

This study shows that combining cross-neutralizing antibodies CV38-142 and COVA1-16 enhances neutralization of SARS-CoV-2 and SARS-CoV pseudoviruses.

bioRxiv · Feb 11, 2021Microbiology

A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model

J. Kreye, S. M. Reincke, H.-C. Kornau, E. Sanchez-Sendin, V. M. Corman, H. Liu, M. Yuan, N. C. Wu, X. Zhu, C.-C. D. Lee, J. Trimpert, M. Hoeltje, K. Dietert, L. Stoeffler, N. von Wardenburg, , N. Osterrieder

This study identifies a potent SARS-CoV-2 neutralizing antibody that protects hamsters from infection and lung damage.

bioRxiv · Aug 15, 2020Immunology